Total words: 1823 | 2-word phrases: 479 | 3-word phrases: 524 | 4-word phrases: 534
| Title | Try to keep the title under 60 characters (51 characters) Clinical-Stage Biopharmaceutical Company | Replicor |
| Description | Try to keep the meta description between 50 - 160 characters (343 characters) Replicor is a clinical-stage biopharmaceutical company developing NUCLEIC ACID POLYMERS (NAPs). These compounds are oligonucleotides whose antiviral activity is strictly dependent on the sequence independent activity of phosphonothioate oligonucleotides as biocompatible polymers that interact with exposed hydrophobic surfaces in proteins. |
| Keywords | Meta keywords are not recommended anymore (0 characters) |
| H1 | No H1 tag on the page (0 characters) |
| # | Keyword | H1 | Title | Des | Volume | Position | Suggest | Frequency | Density |
|---|---|---|---|---|---|---|---|---|---|
| 1 | of | 26 | 9.09% | ||||||
| 2 | the | 20 | 6.99% | ||||||
| 3 | and | 19 | 6.64% | ||||||
| 4 | in | 17 | 5.94% | ||||||
| 5 | is | 8 | 2.80% | ||||||
| 6 | with | 8 | 2.80% | ||||||
| 7 | hepatitis | 8 | 2.80% | ||||||
| 8 | hbsag | 6 | 2.10% | ||||||
| 9 | a | 6 | 2.10% | ||||||
| 10 | antiviral | 6 | 2.10% |
| # | URL | Whois | Check |
|---|